
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 07, 2025, titled "Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 07, 2025, titled "Zydus receives NOC from Health Canada for ZDS-Varenicline Tablets 0.5 &1 mg".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences